Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Aug 15, 2024 9:22am
61 Views
Post# 36180256

RE:RE:VMS+4.0, to Health Canada for approval! 🎉

RE:RE:VMS+4.0, to Health Canada for approval! 🎉

jopatclo wrote: I think of exciting moments. FDA V4.0 and Sales at any time now Insiders know!Post Bart Hendriks I'm excited to share that Ventripoint has just submitted its latest AI-powered heart-scanning technology, VMS+4.0, to Health Canada for approval! This new version is designed to seamlessly integrate into clinical workflows.

and
 Always confident for GEHC, as for China! Interesting (VMS+2.0 is being manufactured and used in leading hospitals in China through a partnership). those thought this partnership was dead! For Brazil? The elephant? I think Dr. Adams the visionary with Ventripoint will surprise us again with the upcoming FDA V4.0

 

 

This didn't age well, nor reassuring with your continued prediction s

 

jopatclo (210)

User Actions  

January 07, 2022 - 11:40 AM

104 Reads

Post# 34293071

RE:games here ... with low volume go VPT $$$

 Last chance to get shares below the PP price?

 

 

jopatclo (210)

User Actions  

October 21, 2021 - 09:42 AM

139 Reads

Post# 34031961

Engines getting lubed up big volume $$ wall 0.53

News to come :-)

 

now we will pass this wall for the highest of the year

 

 

jopatclo (210)

User Actions  

October 20, 2021 - 03:51 PM

132 Reads

Post# 34028882

Engines getting lubed up big volume $$ wall 0.52

 

What if the next NR is a distribution deal with Philips or Siemens.....blastoff

<< Previous
Bullboard Posts
Next >>